Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review

SIMPLE SUMMARY: Bladder cancer is the ninth most common cancer worldwide. Immune checkpoint inhibitors, a novel class of immunotherapy drugs that restore natural antitumoral immune activity, have been applied to improve the overall survival and to reduce the morbidity and mortality of bladder cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Barone, Biagio, Calogero, Armando, Scafuri, Luca, Ferro, Matteo, Lucarelli, Giuseppe, Di Zazzo, Erika, Sicignano, Enrico, Falcone, Alfonso, Romano, Lorenzo, De Luca, Luigi, Oliva, Francesco, Mirto, Benito Fabio, Capone, Federico, Imbimbo, Ciro, Crocetto, Felice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139497/
https://www.ncbi.nlm.nih.gov/pubmed/35626149
http://dx.doi.org/10.3390/cancers14102545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139497/
https://www.ncbi.nlm.nih.gov/pubmed/35626149
http://dx.doi.org/10.3390/cancers14102545

Ejemplares similares